​

Humana (HUM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HUM Stock Forecast

Humana (HUM) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $469.89, with a high of $596.00 and a low of $300.00. This represents a 11.66% increase from the last price of $420.81.

$150 $240 $330 $420 $510 $600 High: $596 Avg: $469.89 Low: $300 Last Closed Price: $420.81

HUM Stock Rating

Humana stock's rating consensus is Hold, based on 44 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (47.73%), 22 Hold (50.00%), 1 Sell (2.27%), and 0 Strong Sell (0.00%).

Hold
Total 44 1 22 21 Strong Sell Sell Hold Buy Strong Buy

HUM Price Target Upside V Benchmarks

TypeNameUpside
StockHumana11.66%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks9.85%

Price Target Trends

1M3M12M
# Anlaysts112163
Avg Price Target$521.27$480.38$347.32
Last Closing Price$420.81$420.81$420.81
Upside/Downside23.87%14.16%-17.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26211121-26
Sep, 26111131-26
Aug, 26111122-26
Jul, 2617162-26
Jun, 2617162-26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 13, 2026Mizuho Securities$495.00$433.5014.19%17.63%
Oct 12, 2026Oppenheimer$525.00$430.1622.05%24.76%
Oct 12, 2026UBS$495.00$431.5014.72%17.63%
Oct 12, 2026David MacDonaldTruist Financial$475.00$431.0310.20%12.88%
Oct 12, 2026Raymond James$520.00$431.0320.64%23.57%
Oct 09, 2026Oppenheimer$475.00$387.1222.70%12.88%
Oct 09, 2026Barclays$582.00$387.1250.34%38.30%
Oct 09, 2026UBS$596.00$387.1253.96%41.63%
Oct 09, 2026Michael HaRobert W. Baird$596.00$387.1253.96%41.63%
Oct 07, 2026Sarah JamesRaymond James$460.00$404.2813.78%9.31%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 12, 2026UBSNeutralNeutralhold
Oct 12, 2026Raymond JamesHoldOutperformupgrade
Oct 09, 2026CitigroupNeutralBuyinitialise
Oct 09, 2026OppenheimerOutperformOutperformhold
Oct 09, 2026Cantor FitzgeraldOverweightOverweighthold
Oct 09, 2026BarclaysOverweightOverweighthold
Oct 07, 2026Cantor FitzgeraldNeutralOverweightupgrade
Sep 25, 2026BarclaysUnderperformerOverweightupgrade
Sep 04, 2026Cantor FitzgeraldNeutralNeutralhold
Aug 24, 2026Wolfe ResearchOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $13 $21 $29 $37 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$22.79$22.20$20.09$10.01$9.87---
Avg Forecast$20.54$25.06$27.17$16.15$16.73$14.11$23.92$38.29
High Forecast$21.49$26.44$27.47$16.29$17.53$16.80$30.54$41.24
Low Forecast$20.04$24.16$25.31$15.89$16.19$11.18$18.59$36.48
Surprise %10.95%-11.41%-26.06%-38.02%-41.00%---

Revenue Forecast

$80B $93B $106B $119B $132B $145B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$83.65B$92.92B$106.44B$117.81B$129.66B---
Avg Forecast$83.07B$92.96B$104.82B$117.02B$119.65B$120.24B$127.73B$134.70B
High Forecast$86.04B$96.92B$105.19B$117.38B$125.04B$120.47B$128.10B$142.69B
Low Forecast$81.54B$90.40B$104.65B$116.54B$116.84B$120.01B$127.35B$129.81B
Surprise %0.69%-0.04%1.55%0.68%8.37%---

Net Income Forecast

$1B $2B $3B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.93B$2.81B$2.49B$1.21B$1.19B---
Avg Forecast$2.79B$2.95B$2.49B$2.00B$2.10B$1.59B$2.40B$4.76B
High Forecast$3.35B$3.55B$2.99B$2.03B$2.18B$2.09B$3.80B$5.13B
Low Forecast$2.22B$2.36B$1.99B$1.98B$2.01B$1.39B$2.31B$4.54B
Surprise %5.24%-4.94%--39.70%-43.38%---

HUM Forecast FAQ

Is Humana stock a buy?

Humana stock has a consensus rating of Hold, based on 44 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 22 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Humana is a neutral investment for most analysts.

What is Humana's price target?

Humana's price target, set by 44 Wall Street analysts, averages $469.89 over the next 12 months. The price target range spans from $300 at the low end to $596 at the high end, suggesting a potential 11.66% change from the previous closing price of $420.81.

How does Humana stock forecast compare to its benchmarks?

Humana's stock forecast shows a 11.66% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (9.85%).

What is the breakdown of analyst ratings for Humana over the past three months?

  • October 2026: 7.69% Strong Buy, 42.31% Buy, 46.15% Hold, 3.85% Sell, 0% Strong Sell.
  • September 2026: 3.85% Strong Buy, 42.31% Buy, 50.00% Hold, 3.85% Sell, 0% Strong Sell.
  • August 2026: 3.85% Strong Buy, 42.31% Buy, 46.15% Hold, 7.69% Sell, 0% Strong Sell.

What is Humana’s EPS forecast?

Humana's average annual EPS forecast for its fiscal year ending in December 2026 is $14.11, marking a 42.96% increase from the reported $9.87 in 2025. Estimates for the following years are $23.92 in 2027, and $38.29 in 2028.

What is Humana’s revenue forecast?

Humana's average annual revenue forecast for its fiscal year ending in December 2026 is $120.24B, reflecting a -7.27% decrease from the reported $129.66B in 2025. The forecast for 2027 is $127.73B, and $134.7B for 2028.

What is Humana’s net income forecast?

Humana's net income forecast for the fiscal year ending in December 2026 stands at $1.59B, representing an 33.49% increase from the reported $1.19B in 2025. Projections indicate $2.4B in 2027, and $4.76B in 2028.